1 T.H. Stanley, 29 : S67-S71, 2005
2 M.E. Mouedden, "The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain" 87 : 30-40, 2007
3 R. Freynhagen, "Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: A prospective, multicenter pilot study in outpatients with chronic pain" 30 : 289-297, 2005
4 M.H. Qvist, "Release of chemical permeation enhancers from drug-in-adhesive transdermal patches" 231 : 253-263, 2002
5 H.S. Tan, "Pressure-sensitive adhesives for transdermal drug delivery systems" 2 : 60-69, 1999
6 M. Bach, "Percutaneous penetration enhancement and its qualification" 46 : 1-13, 1998
7 A.C. Williams, "Penetration enhancers" 56 : 603-618, 2004
8 B. Ebert, "Opioid analgesics as noncompetitive N-methyl-daspartate (NMDA) antagonists-Synthesis and identification of a major metabolite" 56 : 553-559, 1998
9 T. Kotyla, "Increased bioavailability of a transdermal application of a nano-sized emulsion preparation" 347 : 144-148, 2008
10 I. Alberti, "In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum" 71 : 319-327, 2001
1 T.H. Stanley, 29 : S67-S71, 2005
2 M.E. Mouedden, "The impact of the opioids fentanyl and morphine on nociception and bone destruction in a murine model of bone cancer pain" 87 : 30-40, 2007
3 R. Freynhagen, "Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: A prospective, multicenter pilot study in outpatients with chronic pain" 30 : 289-297, 2005
4 M.H. Qvist, "Release of chemical permeation enhancers from drug-in-adhesive transdermal patches" 231 : 253-263, 2002
5 H.S. Tan, "Pressure-sensitive adhesives for transdermal drug delivery systems" 2 : 60-69, 1999
6 M. Bach, "Percutaneous penetration enhancement and its qualification" 46 : 1-13, 1998
7 A.C. Williams, "Penetration enhancers" 56 : 603-618, 2004
8 B. Ebert, "Opioid analgesics as noncompetitive N-methyl-daspartate (NMDA) antagonists-Synthesis and identification of a major metabolite" 56 : 553-559, 1998
9 T. Kotyla, "Increased bioavailability of a transdermal application of a nano-sized emulsion preparation" 347 : 144-148, 2008
10 I. Alberti, "In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum" 71 : 319-327, 2001
11 Y.J. Cho, "Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix" 169 : 95-104, 1998
12 J.-H. Kim, "Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin" 196 : 105-113, 2000
13 P. Minghetti, "Development of local patches containing melilot extract and ex vivoin vivo evaluation of skin permeation" 10 : 111-117, 2000
14 M. Guyot, "Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol" 204 : 171-182, 2000
15 S.D. Roy, "Controlled transdermal delivery of fentanyl: Characterizations of pressure-sensitive adhesives for matrix patch design" 85 : 491-495, 1996
16 T.M. Suhonen, "Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations" 59 : 149-161, 1999